TP A3: Differential roles and cell type specific effects of IL-17A and IL-17F in epidermolysis bullosa acquisita
The project TP A3a continues TP 4 and A3 “The contribution of IL-17A and IL-17F in experimental epidermolysis bullosa acquisita” which have attributed an important role of the cytokine interleukin (IL)-17A in the effector phase of epidermolysis bullosa acquisita (EBA).
In the current study the cell-type specific effects mediated by the IL-17 receptor A on the pathogenesis of EBA is being elucidated.
- Projects
- Projects
- TP A1 - B cell metabolism
- TP A2 - Expression profiling based drug design in EBA
- TP A3 -Differential roles and cell type specific effects of IL-17A and IL-17F in EBA
- TP A4 - Anti-laminin 322 mucous membrane pemphigoid
- TP A5 - C5a/C5aR in autoantibody induction
- TP A6 - Effects of immune-complexes with sialylated IgG antibodies...
- TP A7 - The effect of neutrophil extracellular traps (NETs) on human neutrophils in vitro
- TP B1 - Novel pemphigus animal model
- TP B2 - Autoimmunity alters the T cell receptor repertoire ...
- TP B3 - Metabolomics in autoimmunity
- TP B4 - Organotropism of leukocyte migration
- TP B6 - Pathomechanisms in experimental Systemic Sclerosis
- Associated projects
- MD projects
- Associated MD projects
- Concluded projects
- Projects
